Literature DB >> 31494804

Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.

Saw Simeon1,2, Nathjanan Jongkon3, Warot Chotpatiwetchkul4, M Paul Gleeson5,6.   

Abstract

Protein kinases are an important class of enzymes that play an essential role in virtually all major disease areas. In addition, they account for approximately 50% of the current targets pursued in drug discovery research. In this work, we explore the generation of structure-based quantum mechanical (QM) quantitative structure-activity relationship models (QSAR) as a means to facilitate structure-guided optimization of protein kinase inhibitors. We explore whether more accurate, interpretable QSAR models can be generated for a series of 76 N-phenylquinazolin-4-amine inhibitors of epidermal growth factor receptor (EGFR) kinase by comparing and contrasting them to other standard QSAR methodologies. The QM-based method involved molecular docking of inhibitors followed by their QM optimization within a ~ 300 atom cluster model of the EGFR active site at the M062X/6-31G(d,p) level. Pairwise computations of the interaction energies with each active site residue were performed. QSAR models were generated by splitting the datasets 75:25 into a training and test set followed by modelling using partial least squares (PLS). Additional QSAR models were generated using alignment dependent CoMFA and CoMSIA methods as well as alignment independent physicochemical, e-state indices and fingerprint descriptors. The structure-based QM-QSAR model displayed good performance on the training and test sets (r2 ~ 0.7) and was demonstrably more predictive than the QSAR models built using other methods. The descriptor coefficients from the QM-QSAR models allowed for a detailed rationalization of the active site SAR, which has implications for subsequent design iterations.

Entities:  

Keywords:  3D-QSAR; EGFR kinase; Pairwise interactions; Quantum mechanics; Quinazoline

Mesh:

Substances:

Year:  2019        PMID: 31494804     DOI: 10.1007/s10822-019-00221-z

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  81 in total

1.  A widely applicable set of descriptors.

Authors:  P Labute
Journal:  J Mol Graph Model       Date:  2000 Aug-Oct       Impact factor: 2.518

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

4.  The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR).

Authors:  Juozas Domarkas; Fabienne Dudouit; Christopher Williams; Qiu Qiyu; Ranjita Banerjee; Fouad Brahimi; Bertrand Jacques Jean-Claude
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

5.  GROMACS: fast, flexible, and free.

Authors:  David Van Der Spoel; Erik Lindahl; Berk Hess; Gerrit Groenhof; Alan E Mark; Herman J C Berendsen
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 6.  Quantum mechanics in structure-based drug design.

Authors:  Martin B Peters; Kaushik Raha; Kenneth M Merz
Journal:  Curr Opin Drug Discov Devel       Date:  2006-05

Review 7.  Role of tyrosine kinase inhibitors in cancer therapy.

Authors:  Amit Arora; Eric M Scholar
Journal:  J Pharmacol Exp Ther       Date:  2005-07-07       Impact factor: 4.030

Review 8.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

9.  Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors.

Authors:  Shuang Lü; Wei Zheng; Liyun Ji; Qun Luo; Xiang Hao; Xianchan Li; Fuyi Wang
Journal:  Eur J Med Chem       Date:  2012-07-27       Impact factor: 6.514

10.  CSAR benchmark exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric series.

Authors:  Kelly L Damm-Ganamet; Richard D Smith; James B Dunbar; Jeanne A Stuckey; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2013-05-10       Impact factor: 4.956

View more
  2 in total

1.  Computational Analysis and Biological Activities of Oxyresveratrol Analogues, the Putative Cyclooxygenase-2 Inhibitors.

Authors:  Nathjanan Jongkon; Boonwiset Seaho; Ngampuk Tayana; Saisuree Prateeptongkum; Nongnaphat Duangdee; Panichakorn Jaiyong
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 2.  In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs.

Authors:  Zarko Gagic; Dusan Ruzic; Nemanja Djokovic; Teodora Djikic; Katarina Nikolic
Journal:  Front Chem       Date:  2020-01-08       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.